Qualcomm Expands its Mobile Health Services into Europe
Published on: 12th Nov 2012
Note -- this news article is more than a year old.
Qualcomm Life has announced the availability of its wireless healthcare services offering in Europe. Qualcomm Life's 2net Platform and Hub are designed to enable medical device manufacturers and service providers to wirelessly connect their medical devices via a cloud based solution so that biometric information is easily accessible by device users, their healthcare providers and caregivers.
The 2net Platform and Hub are each individually certified as Class I Medical Devices in Europe, and FDA listed as a Medical Device Data System (MDDS) in the USA.
"We have a number of customers in Europe and the U.S. who want to extend their mobile health solutions in multiple regions around the world, and they need to provide a reliable service that is not impacted by geographic boundaries," said Rick Valencia, vice president and general manager of Qualcomm Life.
Two of Qualcomm Life's first European customers are Telbios and Cystelcom. Telbios is a provider of remote health monitoring solutions for chronic care and disease management in Italy. By connecting to the 2net Platform, Telbios will be able to combine data from several devices into one data stream to allow for improved access and sharing of patient data, improving care coordination for general practitioners.
Cystelcom, an engineering software development company that provides products and services to the telecommunications industry, has formed the newly created mHealthAlert, that offers remote monitoring platform for chronic disease patients. Cystelcom will be distributing Qualcomm Life's 2net Hub in Spain.
"There is a clear imperative for health services providers and manufacturers to invest in remote monitoring solutions to improve patient outcomes and align with preventive care initiatives. Europe's governing bodies have demonstrated a commitment to robust pilots, such as the 3 Million Lives project sponsored by the Department of Health in the U.K.," said Laurent Vandebrouck, managing director of Qualcomm Life Europe.